Citigroup’s aTyr Pharma ATYR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $169K | Buy |
33,333
+33,332
| +3,333,200% | +$169K | ﹤0.01% | 3426 |
|
|
2025
Q1 | $3 | Sell |
1
-104,479
| -100% | -$313K | ﹤0.01% | 4724 |
|
|
2024
Q4 | $378K | Sell |
104,480
-28,503
| -21% | -$103K | ﹤0.01% | 3200 |
|
|
2024
Q3 | $234K | Buy |
+132,983
| New | +$234K | ﹤0.01% | 3478 |
|
|
2024
Q2 | – | Sell |
-78,620
| Closed | -$153K | – | 4909 |
|
|
2024
Q1 | $153K | Hold |
78,620
| – | – | ﹤0.01% | 3394 |
|
|
2023
Q4 | $111K | Buy |
+78,620
| New | +$111K | ﹤0.01% | 3422 |
|
|
2023
Q1 | – | Sell |
-428,460
| Closed | -$938K | – | 4976 |
|
|
2022
Q4 | $938K | Buy |
+428,460
| New | +$938K | ﹤0.01% | 2057 |
|
|
2022
Q2 | – | Sell |
-650
| Closed | -$3K | – | 5783 |
|
|
2022
Q1 | $3K | Buy |
+650
| New | +$3K | ﹤0.01% | 5173 |
|
|
2018
Q1 | – | Sell |
-36
| Closed | -$2K | – | 5038 |
|
|
2017
Q4 | $2K | Sell |
36
-485
| -93% | -$26.9K | ﹤0.01% | 4821 |
|
|
2017
Q3 | $37K | Sell |
521
-36
| -6% | -$2.56K | ﹤0.01% | 3780 |
|
|
2017
Q2 | $27K | Hold |
557
| – | – | ﹤0.01% | 3840 |
|
|
2017
Q1 | $27K | Buy |
557
+21
| +4% | +$1.02K | ﹤0.01% | 3954 |
|
|
2016
Q4 | $16K | Sell |
536
-309
| -37% | -$9.22K | ﹤0.01% | 4444 |
|
|
2016
Q3 | $37K | Buy |
845
+643
| +318% | +$28.2K | ﹤0.01% | 3887 |
|
|
2016
Q2 | $8K | Sell |
202
-364
| -64% | -$14.4K | ﹤0.01% | 4597 |
|
|
2016
Q1 | $31K | Buy |
566
+197
| +53% | +$10.8K | ﹤0.01% | 4450 |
|
|
2015
Q4 | $51K | Buy |
369
+364
| +7,280% | +$50.3K | ﹤0.01% | 4068 |
|
|
2015
Q3 | $1K | Sell |
5
-1
| -17% | -$200 | ﹤0.01% | 5089 |
|
|
2015
Q2 | $1K | Buy |
+6
| New | +$1K | ﹤0.01% | 5382 |
|